IL-6 inhibitor, Tocilizumab found to be effective in reducing severe Covid-19 symptoms

A 195-participant-study found that this drug prolonged survival and lessened inflammation in patients with severe Covid-19.

“Repurposed Tocilizumab in Patients with Severe COVID-19” Jianbo Tian, Huilan Zhang , et al. (Dec 9, 2020) J Immunol ji2000981. doi: 10.4049/jimmunol.2000981.